期刊文献+

转染miR-544a对肺癌细胞侵袭和转移能力的影响 被引量:2

Impact of the transfection of miR-544a on the invasion and metastasis of lung cancer cells
下载PDF
导出
摘要 目的探讨miR-544a对肺癌细胞的侵袭和转移能力的影响及其分子机制。方法用miRNA芯片对非小细胞肺癌(NSCLC)细胞系95C和95D进行miRNA谱系分析,并用荧光定量PCR验证其miR-544a表达水平;用Targetscan软件预测miR-544a的靶基因;Transwell实验观察细胞的侵袭转移能力的变化;western blot验证其表达。结果 miRNA芯片及荧光定量PCR结果显示,与95C细胞(1.00±0.00)比较,miR-544a在95D细胞中表达上调(2.95±0.26,t=12.94,P<0.05);Transwell实验结果显示,95C转染miR-544a mimic后增加(32.00±1.00,q=18.67,P<0.01),95D转染miR-544a inhibitor后,侵袭和转移能力降低(11.00±1.00,q=13.67,P<0.01);Targetscan软件预测E-钙粘连素(CDH1)可能为miR-544a的靶基因;western blot显示,95C转染miR-544a mimic后,CDH1表达下调,vimentin表达上调(0.202±0.017,0.574±0.009,q分别为63.86,9.45,P均<0.01);而95D转染miR-544a inhibitor后,CDH1表达上调,而vimentin表达下调(0.769±0.014,0.320±0.020,q分别为18.67,5.99,P均<0.01)。结论 miR-544a可能通过下调CDH1和上调vimentin的表达来促进肺癌细胞的侵袭和转移。 Objective To investigate the impact of miR-544a on the invasion metastasis of lung cancer cells and its molecular mecha- nism. Methods miRNA expressions of non-small cell lung cancer (NSCLC) cell lines, 95C and 95D, were analyzed by miRNA mi- croarray, and the expression level of miR-544a was further determined by real-time quantitative PCR. The target genes of miR-544a were predicted by the Targetscan software. Then, the invasion and metastasis ability of 95C and 95D cells was detected by the Tran- swell test, and the expression of the target genes by western blot. Results The level of miR-544a expression in 95D cells was signifi- cantly higher than that in 95C cells (2.95 ± 0.26 vs 1.00 ± 0.00, t = 12.94, P 〈 0.05). After 95C ceils were transfected with miR- 544a mimic, the number of cells was increased significantly (32.00± 1.00 vs 13.33 ±0.01, q = 18.67, P 〈0.01 ), and the expres- sion of E-cadherin ( CDH1 ) down-regnlated (0.202 ± 0.017 vs 0.841± 0. 052, q = 63.86, P 〈 0.01 ) and that of vimentin up-regula- ted (0. 574± 0.009 vs 0.479± 0.011, q = 9.45, P 〈 0.01 ). After 95 D cells were transfected with miR-544a inhibitor, the number of cells was decreased obviously ( 11.00 ± 1.00 vs 24.67 ± 0.58, q = 13.67, P 〈 0.01 ), and the expression of CDH1 up-regulated (0.769 ±0.014 vs 0.583 ± 0.010, q = 18. 67, P 〈 0.01 ) and that of vimentin down-regulated (0. 320 ± 0. 020 vs 0.919 ± 0. 019, q = 5.99, P 〈 0.01 ). Targetscan predicted that CDH1 may be the target gene of miR-544a. Conclusion miR-544a promotes the in- vasion and metastasis of lung cancer cells probably by the down-regulation of CDH1 and the up-regulation of vimentin.
出处 《临床检验杂志》 CAS CSCD 北大核心 2013年第11期852-855,共4页 Chinese Journal of Clinical Laboratory Science
关键词 微小RNA-544a 非小细胞肺癌 E-钙粘连素 波形蛋白 侵袭 miR-544a non-small cell lung cancer E-cadherin vimentin invasion
  • 相关文献

参考文献1

二级参考文献10

  • 1Liu X, Sempere LF, Ouyang H, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by re- pressing specific tumor suppressors [ J]. J Clin Invest, 2010, 120 (4) :1298-1309.
  • 2Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation [ J ]. Cancer Res, 2005,65 (21) :9628-9632.
  • 3Seike M, Goto A, Okano T, eta(. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers [ J ]. Proc Natl Acad Sci USA, 2009,106 ( 29 ) : 12085 -12090.
  • 4Garofalo M, Di Leva G, Romano G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down-regulation[ J]. Cancer Cell, 2009,16 (6) :498-509.
  • 5Liu B, Peng XC, Zheng XL, et al. MiR-126 restoration downregu- late VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo[J]. Lung Cancer, 2009,66(2) :169-175.
  • 6Shi B, Sepp-LorenzinoL, PriscoM, et al. MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells[J]. J Biol Chem, 2007,282(45 ) :32582-32590.
  • 7Livak K J, Sehmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△Ct method[ J]. Meth- ods, 2001,25(4) :402-408.
  • 8Garofalo M, Quintaballe C, Di Leva G, et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer[J]. Onco- gene, 2008,27 ( 27 ) : 3845-3855.
  • 9Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines [ J ]. Biochem Biophy Res Commun, 2008,373 (4) :607-612.
  • 10辇伟奇,陈芳琳,敖绪军,陈正堂.miR-223在CXCR4^+ Lewis肺癌细胞中的显著低表达及其靶基因预测[J].第三军医大学学报,2009,31(22):2202-2205. 被引量:2

共引文献15

同被引文献9

  • 1Li Y, Liu M, Zhang Y,et al. Effects of ARHI on breast cancer cell bi- ological behacior regulated by microRNA-22 [ J]. Tumor Biol,2013, 34(6) :3545-3554.
  • 2Jiao X,Zhao L, Ma M, et al. MiR-181 a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resitance protein (BCRP/ABCG) [ J ]. Breast Cancer Res Treat, 2013,139(3) :717-730.
  • 3Bisso A, Faleschini M, Zampa F,et al. Oncogenic miR-181 a/b affect the DNA damage response in aggressive breast cancer[ J]. Cell Cy- cle ,2013,12 ( 11 ) : 1679-1687.
  • 4Teichler S, Illmer T, Roemhild J, et al. MicroRNA29a regulates the expression of the nuclear oncogene Ski[ J ]. Blood, 2011 , 118 ( 7 ) : 1899-1902.
  • 5Cui Y, Su WY, Xing J, et al. miR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer[J]. PLoS One, 2011, 6(10) :e25872.
  • 6Kong G, Zhang J, Zhang S, et al. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by tar- geting PTEN in celt culture model [ J ]. PLoS One, 2011, 6 (5) :e19518.
  • 7Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015, 65(2) :87-108.
  • 8Abdulkareem IH, Blair M. Phosphatase and tensin homologue dele- ted on chromosome 10[J]. Niger Med J, 2013, 54(2) :79-86.
  • 9熊佳时,何刚,李士英,朱英,蒋建龙,何忠惠,张明.非小细胞肺癌患者外周血T细胞亚群、NK细胞与临床分期及预后的相关性[J].临床肺科杂志,2015,20(7):1183-1186. 被引量:26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部